News

Immunetune joins the fight against Sars-CoV-2

Immunetune joins the fight against Sars-CoV-2

Within a newly established consortium, Immunetune will develop enhanced DNA vaccines against SARS-CoV-2 and other human coronaviruses. The vaccine is built on the combination of two strong synthetic vaccine platforms and the inclusion of conserved T and B cell...

read more
Finalist RESI Innovation Challenge

Finalist RESI Innovation Challenge

Immunetune is proud to have been selected as a finalist for the 2020 RESI Innovation Challenge! We will be presenting on the 23rd of March 2020 at the RESI 2020 Europe Conference in Paris.

read more